Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder... Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765. Show more
Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex PR Newswire WASHINGTON, July 1, 2024 WASHINGTON, July 1, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc...
Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders PR Newswire WASHINGTON, June 19...
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak PR Newswire WASHINGTON, June 13, 2024 No Shareholder Action Required at This Time WASHINGTON, June...
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd. PR Newswire WASHINGTON, June 6, 2024 No Shareholder Action Required at...
Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference PR Newswire WASHINGTON, May 30, 2024 WASHINGTON, May 30, 2024 /PRNewswire/ -- Vanda...
Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY® PR Newswire WASHINGTON, May 30, 2024 WASHINGTON, May 30, 2024 /PRNewswire/ -- Vanda...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.26 | 4.2904290429 | 6.06 | 6.365 | 5.89 | 766422 | 6.18835037 | CS |
4 | 0.41 | 6.93739424704 | 5.91 | 6.365 | 5.13 | 850120 | 5.76051658 | CS |
12 | 1.54 | 32.2175732218 | 4.78 | 6.75 | 4.62 | 1234016 | 5.68146492 | CS |
26 | 2.45 | 63.3074935401 | 3.87 | 6.75 | 3.46 | 1763336 | 5.01097469 | CS |
52 | -0.21 | -3.21592649311 | 6.53 | 6.75 | 3.295 | 1421999 | 4.79452461 | CS |
156 | -13.18 | -67.5897435897 | 19.5 | 21.4399 | 3.295 | 819070 | 7.27365207 | CS |
260 | -6.18 | -49.44 | 12.5 | 21.8627 | 3.295 | 717511 | 9.32134603 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.